Attention deficit hyperactivity disorder. Disturbance of activity and attention
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Participant including major eligibility inclusion criteria are patients with the diagnosis of attention deficit hyperactivity disorder by a psychiatrist; child aged 7-12 years; children receive pharmacotherapy by Risperidone or Ritalin; their parent have minimum education level of diploma; having willingness to participate in the research. Exclusion criteria: Parent or child with diagnosis of intellectual disability by a psychiatrist; child have bipolar concurrent disorder; psychiatrist change dosage of drug child.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Parental parenting stress. Timepoint: Before intervention, after intervention, two month after intervention. Method of measurement: Parenting stress index- short form (PSI-SF36). | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical symptoms. Timepoint: Before intervention, after intervention, two month after intervention. Method of measurement: Swanson, Nolan and Pelham parenting rating scale (SNAP-IV) (diagnosis and classification of attention deficit hyperactivity disorder).;Self-efficacy for children. Timepoint: Before intervention, after intervention, two month after intervention. Method of measurement: Children self-efficacy questionnaire (SEQ-C). | — |
Countries
Iran (Islamic Republic of)
Contacts
Kashan University of Medical Sciences and Health Services